Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGSNOW: Low Dose MagTrace for Sentinel Node Detection
NCT05359783Phase 2Completed
- Sponsor
- Region Västra Götaland
- Start
- Nov 2021
- Primary completion
- Feb 2023
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Magtrace in breast cancer, sponsored by Region Västra Götaland. Started Nov 2021; status: completed.
02
Drugs
Magtrace
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05359783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05359783.